Primary hyperparathyroidism is a rare cause of acute pancreatitis with a rather uncommon association according to existing literature. We present a rare case of recurrent pancreatitis with primary hyperparathyroidism resulting from a solitary parathyroid adenoma detected by a dual-phase singleisotope imaging protocol using technetium pertechnetate and technetium sestamibi followed by a single-photon emission computed tomography (SPECT)-CT. The case demonstrates the requirement of a high index of suspicion of primary hyperparathyroidism as one of the etiologies in patients presenting with recurrent pancreatitis. This case highlights the role of dualphase single-isotope imaging (technetium pertechnetate and technetium sestamibi scan) along with SPECT-CT for precise anatomical localization of a parathyroid adenoma, which is of paramount importance to the surgeon for meticulous planning and execution of the surgical procedure.
INTRODUCTION
Primary hyperparathyroidism is a rare cause of recurrent pancreatitis, especially in young adult males. Primary hyperparathyroidism, usually presenting as a solitary adenoma, is more prevalent in females above the age of 1 The incidence is less than 5% in adolescents and young adults aged 12 to 28 years, 2 A solitary adenoma is responsible for 80% of cases of primary hyperparathyroidism. 3 We present a case of recurrent pancreatitis associated with primary hyperparathyroidism. Dual-phase single-isotope planar imaging with technetium pertechnetate and technetium sestamibi was performed on two separate days along with single-photon emission computed tomography (SPECT)-CT to detect the precise anatomical localization of a solitary parathyroid adenoma.
CASE REPORT
A 25-year-old male presented with a history of abdominal and recurrent episodes of vomiting for a duration of 12 hours. The pain was acute in onset, located in the epigastrium initially and later spread to the entire upper abdomen, radiating to the back and partially relieved on bending forward. The pain was dull aching in character, which gradually increased in intensity over a period of 2 hours and thereafter remained unaltered in intensity. The pain was also associated with multiple episodes of nonprojectile, nonbilious, and nonblood-stained vomiting. The symptoms were also associated with abdominal distension and loss of appetite. There was no history of fever, jaundice, cough, dysuria, hematuria, upper gastrointestinal bleed, or drug intake. The patient gave a history of two similar episodes in the preceding 2 years. Clinical examination revealed tenderness and guarding in the epigastrium along with tachycardia (pulse 136/min). Initial investigations revealed anemia (hemoglobin 11.2 g/dL), elevated serum amylase (1100 U/L), elevated serum lipase (2860 U/L), and hypercalcemia (12.2 mg/dL, reference range: 8.9 to 10.3 mg/dL). The liver function tests, serum proteins, albumin, lipid profile, electrolytes, and phosphorus levels were within normal limits. Ultrasonography of abdomen revealed a diffusely enlarged pancreas along with distended gallbladder. There was no evidence of necrosis or calcification. Contrast-enhanced computed tomography of abdomen performed subsequently revealed a bulky pancreas with homogenous enhancement and peripancreatic fat stranding. The main pancreatic duct was not dilated and no stones were found. Based on the above findings, a provisional diagnosis of acute pancreatitis was made. The etiology was suspected to be likely due to hypercalcemia. The patient was managed conservatively for the same. Further detailed investigations were carried out to confirm and manage the likely etiology. In view of hypercalcemia, the patient was investigated to determine the serum parathormone level, which was found to be elevated (147.55 pg/mL, reference range: 10 to 65 pg/mL) with normal thyroid function tests. An ultrasound of the neck revealed a colloid cyst in the right lobe of thyroid. The patient was sent to the Department of Nuclear Medicine and was subjected to a dual-phase single-isotope planar imaging study with technetium pertechnetate and technetium sestamibi on two separate days (Fig. 1) . The technetium thyroid scan on day 1 revealed a large photopenic area in the inferior pole of the right lobe of thyroid. The technetium sestamibi study performed on a subsequent day revealed a focus of increased tracer uptake in the inferior pole of the right lobe of the thyroid, with a complete tracer washout from the rest of the thyroid after 120 minutes of study. The planar imaging was positive for parathyroid adenoma at the inferior pole of the right lobe of thyroid. This finding was corroborated with SPECT-CT, which further delineated and localized the lesion to the inferior pole of the right lobe of thyroid (Fig. 2) . Subsequent magnetic resonance imaging also corroborated the above findings. The patient was, therefore, taken up for surgical removal of the parathyroid adenoma. Postoperative histopathological examination confirmed the presence of parathyroid adenoma (Figs 3 and 4) . Following the surgery, the patient was asymptomatic and serum amylase, lipase, and calcium levels returned to normal limits. A postoperative parathormone assay was also normal (0.01 pg/mL).
DISCUSSION
We have presented a rare case of recurrent pancreatitis due to primary hyperparathyroidism resulting from a solitary parathyroid adenoma detected by a dual-phase single-isotope imaging protocol using technetium pertechnetate and technetium sestamibi. The diagnosis of primary hyperparathyroidism depends on the laboratory confirmation of increased serum calcium and parathormone levels. The incidence of acute pancreatitis associated with hyperparathyroidism is reported to be <10%. 4, 5 According to existing literature, the association between pancreatitis and primary hyperparathyroidism appears to be rather uncommon. The likely mechanism of hyperparathyroidism leading to acute pancreatitis is that hypercalcemia may cause activation of trypsinogen to trypsin, resulting in autodigestion of the pancreas. Subsequently, it may also lead to the formation of pancreatic calculi, pancreatic ductal obstruction, and subsequent attacks of acute or chronic pancreatitis. 6 Studies have also shown that hypercalcemia in combination with genetic variants in serine protease inhibitor kazal type 1 (SPINK1) and cystic fibrosis transmembrane conductance regulator (CFTR) genes can increase the risk of developing acute pancreatitis in patients with primary hyperparathyroidism. 7 A study by Bai et al 8 reviewed the association between acute pancreatitis and primary hyperparathyroidism. The study reported that the published cohorts of patients were subject to bias, because serum calcium screening was not universally performed among all control patients. They also concluded that hypercalcemia may contribute to pancreatitis in these cases, along with genetic or environmental insults. The Mayo Clinic experience between 1950 and 1975 found that out of 1,153 patients with primary hyperparathyroidism, only 17 (1.5%) had coexisting pancreatitis. Other factors of possible etiologic significance in pancreatitis, such as gallstones or alcohol abuse, were present in 11 of 17 patients. 9 Misgar et al 10 reported the case of a 32-year-old man who was diagnosed to have primary hyperparathyroidism during the fourth attack of pancreatitis and his post operative recovery period was uneventful. Agarwal et al 11 reported
that pancreatitis was found to be associated with primary hyperparathyroidism in 6 of 87 patients (6.8%), and despite its rarity, a cause and effect relationship was still suggested by the fact that parathyroidectomy seems to prevent recurrence of pancreatitis. Krishnamurthy et al 12 also reported the association between giant parathyroid adenoma and recurrent pancreatitis. They effectively pointed out that preoperative localization techniques that would include a parathyroid scintigraphy and a focused surgical intervention are important to resolve complications and improve clinical outcomes. Precise preoperative localization of the parathyroid adenoma is essential for surgical management. The use of single-isotope dual-phase scintigraphic imaging technique is based on the observation that technetium sestamibi washes out more rapidly from the thyroid gland than from the hyperfunctioning parathyroid glands. 13 This is due to the increased number of mitochondria in the parathyroid adenomatous cells that concentrates the technetium sestamibi. The use of SPECT-CT along with technetium sestamibi is more superior than the planar study alone, in the accurate preoperative localization of the hyperfunctioning pathologic glands, especially in patients suffering from multiglandular disease with primary hyperparathyroidism.
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CONCLUSION
This case further reiterates the rare association between primary hyperparathyroidism and recurrent pancreatitis with the requirement of a high index of suspicion to detect the same along with the role of early serum calcium estimation in cases of acute pancreatitis. The case also highlights the role of dual-phase single-isotope imaging (technetium sestamibi and technetium thyroid scan) in clinching the etiological diagnosis. The SPECT-CT component in the study has an added benefit of precise anatomical localization of the tumor in the parathyroid glands, which is of paramount importance to the surgeon for planning and execution of the surgery and also to improve the surgical outcome.
